Serena Williams has made a limited partner commitment to the dating app's impact investment fund, which targets female-led startups.

The Y Combinator graduate collected $11.5m in a round that included contributions from Tencent, ServiceNow, Presidio Ventures and GMO Ventures.

Sana has emerged with funding from investors including F-Prime Capital, Arch and Flagship Pioneering to develop genetically modified hypoimmogenic stem cells.

Online mattress retailer Casper Sleep is looking to hire underwriters for an initial public offering that would allow Target to exit two years after leading its $170m series C round.

Hookipa Pharma, a Boehringer Ingelheim, Takeda and Gilead-backed infectious disease and cancer drug developer, has filed for an $86.3m IPO.

The lidar technology developer has followed a $27m series A round by adding $60m from investors including existing backers Cox Enterprises and Exelon.

Roche Venture Fund was among the existing investors that helped supply $50m for Arch Oncology, the cancer drug developer formerly known as Tioma.

SoftBank Vision Fund investor Lydia Jett has been appointed to a partner position, having worked with portfolio companies such as Flipkart, Coupang and Tokopedia.

The Bloomberg-backed cybersecurity technology developer reeled in $26m in a round co-led by Sorenson Ventures, Lytical Ventures and Edison Partners.

The Mitsui-backed glucose monitoring technology provider will use the series E proceeds to fund the commercialisation of its device in the US.